Home The History of Synthetic Biology Designing Synthetic Biotics Pipeline Our People Leadership Board of Directors Founders and Advisors Investors + Media Company Overview News News Releases In the News Events & Presentations Events Presentations Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update Read more about Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update Synlogic Announces Leadership Change Read more about Synlogic Announces Leadership Change Synlogic Receives Fast-Track Designation for SYNB1618, a Synthetic Biotic™ medicine for the Treatment of Phenylketonuria Read more about Synlogic Receives Fast-Track Designation for SYNB1618, a Synthetic Biotic™ medicine for the Treatment of Phenylketonuria Synlogic Doses First Subject in Phase 1/2a Trial of SYNB1618 for Treatment of Phenylketonuria Read more about Synlogic Doses First Subject in Phase 1/2a Trial of SYNB1618 for Treatment of Phenylketonuria Synlogic Presents Preclinical Data from Synthetic Biotic Immuno-Oncology Program at the American Association for Cancer Research 2018 Annual Meeting Read more about Synlogic Presents Preclinical Data from Synthetic Biotic Immuno-Oncology Program at the American Association for Cancer Research 2018 Annual Meeting Synlogic Announces Registered Direct Offering of Common Stock Read more about Synlogic Announces Registered Direct Offering of Common Stock Synlogic Doses First Patient in Phase 1b/2a Trial of SYNB1020 for Treatment of Hyperammonemia in Patients with Cirrhosis Read more about Synlogic Doses First Patient in Phase 1b/2a Trial of SYNB1020 for Treatment of Hyperammonemia in Patients with Cirrhosis Synlogic to Present at the 17th Annual Needham Healthcare Conference Read more about Synlogic to Present at the 17th Annual Needham Healthcare Conference Synlogic Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Read more about Synlogic Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Synlogic to Present Data at the American Association for Cancer Research 2018 Annual Meeting Read more about Synlogic to Present Data at the American Association for Cancer Research 2018 Annual Meeting Pagination First page « First Previous page ‹ Previous … Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Page 21 Page 22 Page 23 … Next page Next › Last page Last » Subscribe to Investor Resources Contact IR Investor FAQs RSS Feeds Investor Email Alerts Email
Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update Read more about Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update
Synlogic Receives Fast-Track Designation for SYNB1618, a Synthetic Biotic™ medicine for the Treatment of Phenylketonuria Read more about Synlogic Receives Fast-Track Designation for SYNB1618, a Synthetic Biotic™ medicine for the Treatment of Phenylketonuria
Synlogic Doses First Subject in Phase 1/2a Trial of SYNB1618 for Treatment of Phenylketonuria Read more about Synlogic Doses First Subject in Phase 1/2a Trial of SYNB1618 for Treatment of Phenylketonuria
Synlogic Presents Preclinical Data from Synthetic Biotic Immuno-Oncology Program at the American Association for Cancer Research 2018 Annual Meeting Read more about Synlogic Presents Preclinical Data from Synthetic Biotic Immuno-Oncology Program at the American Association for Cancer Research 2018 Annual Meeting
Synlogic Announces Registered Direct Offering of Common Stock Read more about Synlogic Announces Registered Direct Offering of Common Stock
Synlogic Doses First Patient in Phase 1b/2a Trial of SYNB1020 for Treatment of Hyperammonemia in Patients with Cirrhosis Read more about Synlogic Doses First Patient in Phase 1b/2a Trial of SYNB1020 for Treatment of Hyperammonemia in Patients with Cirrhosis
Synlogic to Present at the 17th Annual Needham Healthcare Conference Read more about Synlogic to Present at the 17th Annual Needham Healthcare Conference
Synlogic Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Read more about Synlogic Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
Synlogic to Present Data at the American Association for Cancer Research 2018 Annual Meeting Read more about Synlogic to Present Data at the American Association for Cancer Research 2018 Annual Meeting